Global Cancer Drug Therapy Market Insights, Forecast to 2025

Publisher Name :
Date: 19-Jun-2019
No. of pages: 124
Inquire Before Buying

Kidney cancer or renal cancer is one of the ten most frequently diagnosed cancers, found mainly in people aged 60 or above. According to the estimates of the American Cancer Society (ACS), 61,560 new kidney cancer cases and 14,080 deaths would occur in 2015. Due to the increasing prevalence with no cure of this deadly disease, till date, there is an imminent need for effective kidney cancer drugs.

The renal cancer drug therapy market has witnessed a dramatic change in its treatment paradigm over the last three decades. Although, there are a variety of treatment options available, innovators have now shifted their focus towards more targeted therapies and immunotherapies. The market is primarily driven by lifestyle affecting factors such as reduced physical activity, excessive smoking and drinking. Rising aging population and the mounting prevalence of kidney cancer cases are some of the additional factors boosting the growth of the market. Strong pipeline and fast-emerging treatments are expected to further boost the market during the analysis period. However, high cost of drugs, looming off-patents and uncertain reimbursement policies are some of the factors that are likely to restrain the market growth.

Winning a physicians confidence regarding the cost, efficacy and dosage would lead to a higher acceptance of drugs in the market. Additionally, immunotherapies would emerge as an opportunity for innovators in the kidney cancer drugs market. Furthermore, untapped geographies with a high undiagnosed patient base would offer lucrative opportunities for the innovators in future. However, overcoming the generic drugs competition would be a key challenge for the leading innovators.

The global Cancer Drug Therapy market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cancer Drug Therapy market based on company, product type, end user and key regions.

This report studies the global market size of Cancer Drug Therapy in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cancer Drug Therapy in these regions.

This research report categorizes the global Cancer Drug Therapy market by top players/brands, region, type and end user. This report also studies the global Cancer Drug Therapy market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Amgen / Allergan

- Argos Therapeutics

- AstraZeneca

- Aveo Pharmaceuticals

- Bayer

- Exelixis

- Incyte

- Merck

- Roche

- Bristol-Myers Squibb

- Eisai

- Exelixis

- Genentech (Roche)

- Novartis

- Pfizer

- Prometheus Labs

Market size by Product

- Targeted Therapy

- Chemotherapy

- Immunotherapy

Market size by End User

- Angiogenesis Inhibitors

- mTOR Inhibitors

- Monoclonal Antibodies

- Cytokine Immunotherapy (IL-2)

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Cancer Drug Therapy market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Cancer Drug Therapy market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Cancer Drug Therapy companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Cancer Drug Therapy submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Cancer Drug Therapy are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cancer Drug Therapy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Cancer Drug Therapy Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Cancer Drug Therapy Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Cancer Drug Therapy Market Size Growth Rate by Product
1.4.2 Targeted Therapy
1.4.3 Chemotherapy
1.4.4 Immunotherapy
1.5 Market by End User
1.5.1 Global Cancer Drug Therapy Market Size Growth Rate by End User
1.5.2 Angiogenesis Inhibitors
1.5.3 mTOR Inhibitors
1.5.4 Monoclonal Antibodies
1.5.5 Cytokine Immunotherapy (IL-2)
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Cancer Drug Therapy Market Size
2.1.1 Global Cancer Drug Therapy Revenue 2014-2025
2.1.2 Global Cancer Drug Therapy Sales 2014-2025
2.2 Cancer Drug Therapy Growth Rate by Regions
2.2.1 Global Cancer Drug Therapy Sales by Regions
2.2.2 Global Cancer Drug Therapy Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Cancer Drug Therapy Sales by Manufacturers
3.1.1 Cancer Drug Therapy Sales by Manufacturers
3.1.2 Cancer Drug Therapy Sales Market Share by Manufacturers
3.1.3 Global Cancer Drug Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Cancer Drug Therapy Revenue by Manufacturers
3.2.1 Cancer Drug Therapy Revenue by Manufacturers (2014-2019)
3.2.2 Cancer Drug Therapy Revenue Share by Manufacturers (2014-2019)
3.3 Cancer Drug Therapy Price by Manufacturers
3.4 Cancer Drug Therapy Manufacturing Base Distribution, Product Types
3.4.1 Cancer Drug Therapy Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cancer Drug Therapy Product Type
3.4.3 Date of International Manufacturers Enter into Cancer Drug Therapy Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Cancer Drug Therapy Sales by Product
4.2 Global Cancer Drug Therapy Revenue by Product
4.3 Cancer Drug Therapy Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Cancer Drug Therapy Breakdown Data by End User
6 North America
6.1 North America Cancer Drug Therapy by Countries
6.1.1 North America Cancer Drug Therapy Sales by Countries
6.1.2 North America Cancer Drug Therapy Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Cancer Drug Therapy by Product
6.3 North America Cancer Drug Therapy by End User
7 Europe
7.1 Europe Cancer Drug Therapy by Countries
7.1.1 Europe Cancer Drug Therapy Sales by Countries
7.1.2 Europe Cancer Drug Therapy Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Cancer Drug Therapy by Product
7.3 Europe Cancer Drug Therapy by End User
8 Asia Pacific
8.1 Asia Pacific Cancer Drug Therapy by Countries
8.1.1 Asia Pacific Cancer Drug Therapy Sales by Countries
8.1.2 Asia Pacific Cancer Drug Therapy Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Cancer Drug Therapy by Product
8.3 Asia Pacific Cancer Drug Therapy by End User
9 Central & South America
9.1 Central & South America Cancer Drug Therapy by Countries
9.1.1 Central & South America Cancer Drug Therapy Sales by Countries
9.1.2 Central & South America Cancer Drug Therapy Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Cancer Drug Therapy by Product
9.3 Central & South America Cancer Drug Therapy by End User
10 Middle East and Africa
10.1 Middle East and Africa Cancer Drug Therapy by Countries
10.1.1 Middle East and Africa Cancer Drug Therapy Sales by Countries
10.1.2 Middle East and Africa Cancer Drug Therapy Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Cancer Drug Therapy by Product
10.3 Middle East and Africa Cancer Drug Therapy by End User
11 Company Profiles
11.1 Amgen / Allergan
11.1.1 Amgen / Allergan Company Details
11.1.2 Company Business Overview
11.1.3 Amgen / Allergan Cancer Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Amgen / Allergan Cancer Drug Therapy Products Offered
11.1.5 Amgen / Allergan Recent Development
11.2 Argos Therapeutics
11.2.1 Argos Therapeutics Company Details
11.2.2 Company Business Overview
11.2.3 Argos Therapeutics Cancer Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Argos Therapeutics Cancer Drug Therapy Products Offered
11.2.5 Argos Therapeutics Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 Company Business Overview
11.3.3 AstraZeneca Cancer Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
11.3.4 AstraZeneca Cancer Drug Therapy Products Offered
11.3.5 AstraZeneca Recent Development
11.4 Aveo Pharmaceuticals
11.4.1 Aveo Pharmaceuticals Company Details
11.4.2 Company Business Overview
11.4.3 Aveo Pharmaceuticals Cancer Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Aveo Pharmaceuticals Cancer Drug Therapy Products Offered
11.4.5 Aveo Pharmaceuticals Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Company Business Overview
11.5.3 Bayer Cancer Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Bayer Cancer Drug Therapy Products Offered
11.5.5 Bayer Recent Development
11.6 Exelixis
11.6.1 Exelixis Company Details
11.6.2 Company Business Overview
11.6.3 Exelixis Cancer Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Exelixis Cancer Drug Therapy Products Offered
11.6.5 Exelixis Recent Development
11.7 Incyte
11.7.1 Incyte Company Details
11.7.2 Company Business Overview
11.7.3 Incyte Cancer Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Incyte Cancer Drug Therapy Products Offered
11.7.5 Incyte Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Company Business Overview
11.8.3 Merck Cancer Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Merck Cancer Drug Therapy Products Offered
11.8.5 Merck Recent Development
11.9 Roche
11.9.1 Roche Company Details
11.9.2 Company Business Overview
11.9.3 Roche Cancer Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Roche Cancer Drug Therapy Products Offered
11.9.5 Roche Recent Development
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Details
11.10.2 Company Business Overview
11.10.3 Bristol-Myers Squibb Cancer Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Bristol-Myers Squibb Cancer Drug Therapy Products Offered
11.10.5 Bristol-Myers Squibb Recent Development
11.11 Eisai
11.12 Exelixis
11.13 Genentech (Roche)
11.14 Novartis
11.15 Pfizer
11.16 Prometheus Labs
12 Future Forecast
12.1 Cancer Drug Therapy Market Forecast by Regions
12.1.1 Global Cancer Drug Therapy Sales Forecast by Regions 2019-2025
12.1.2 Global Cancer Drug Therapy Revenue Forecast by Regions 2019-2025
12.2 Cancer Drug Therapy Market Forecast by Product
12.2.1 Global Cancer Drug Therapy Sales Forecast by Product 2019-2025
12.2.2 Global Cancer Drug Therapy Revenue Forecast by Product 2019-2025
12.3 Cancer Drug Therapy Market Forecast by End User
12.4 North America Cancer Drug Therapy Forecast
12.5 Europe Cancer Drug Therapy Forecast
12.6 Asia Pacific Cancer Drug Therapy Forecast
12.7 Central & South America Cancer Drug Therapy Forecast
12.8 Middle East and Africa Cancer Drug Therapy Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cancer Drug Therapy Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Cancer Drug Therapy Product Picture
Table Cancer Drug Therapy Market Segments
Table Key Manufacturers Cancer Drug Therapy Covered
Table Global Cancer Drug Therapy Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Cancer Drug Therapy Sales Market Share by Product 2014-2025
Figure Targeted Therapy Product Picture
Table Major Manufacturers of Targeted Therapy
Figure Chemotherapy Product Picture
Table Major Manufacturers of Chemotherapy
Figure Immunotherapy Product Picture
Table Major Manufacturers of Immunotherapy
Table Global Cancer Drug Therapy Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Angiogenesis Inhibitors
Figure mTOR Inhibitors
Figure Monoclonal Antibodies
Figure Cytokine Immunotherapy (IL-2)
Figure Cancer Drug Therapy Report Years Considered
Figure Global Cancer Drug Therapy Market Size 2014-2025 (Million US$)
Figure Global Cancer Drug Therapy Sales 2014-2025 (K Units)
Table Global Cancer Drug Therapy Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Cancer Drug Therapy Sales by Regions 2014-2019 (K Units)
Table Global Cancer Drug Therapy Sales Market Share by Regions 2014-2019
Figure Global Cancer Drug Therapy Sales Market Share by Regions 2014-2019
Figure 2018 Global Cancer Drug Therapy Sales Market Share by Regions
Table Global Cancer Drug Therapy Revenue by Regions 2014-2019 (Million US$)
Table Global Cancer Drug Therapy Revenue Market Share by Regions 2014-2019
Figure Global Cancer Drug Therapy Revenue Market Share by Regions 2014-2019
Figure 2018 Global Cancer Drug Therapy Revenue Market Share by Regions
Table Global Cancer Drug Therapy Sales by Manufacturers (2014-2019) (K Units)
Table Global Cancer Drug Therapy Sales Share by Manufacturers (2014-2019)
Figure Global Cancer Drug Therapy Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Cancer Drug Therapy Revenue by Manufacturers (2014-2019) (Million USD)
Table Cancer Drug Therapy Revenue Share by Manufacturers (2014-2019)
Figure Cancer Drug Therapy Value Share by Manufacturers in 2018
Table Key Manufacturers Cancer Drug Therapy Price (2014-2019) (USD/Unit)
Table Cancer Drug Therapy Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Cancer Drug Therapy Product Type
Table Date of International Manufacturers Enter into Cancer Drug Therapy Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Cancer Drug Therapy Sales by Product (2014-2019) (K Units)
Table Global Cancer Drug Therapy Sales Share by Product (2014-2019)
Figure Global Cancer Drug Therapy Sales Market Share by Product (2014-2019)
Figure Global Cancer Drug Therapy Sales Market Share by Product in 2018
Table Global Cancer Drug Therapy Revenue by Product (2014-2019) (Million US$)
Table Global Cancer Drug Therapy Revenue Share by Product (2014-2019)
Figure Global Cancer Drug Therapy Revenue Market Share by Product (2014-2019)
Figure Global Cancer Drug Therapy Revenue Market Share by Product in 2018
Table Cancer Drug Therapy Price by Product 2014-2019 (USD/Unit)
Table Global Cancer Drug Therapy Sales by End User (2014-2019) (K Units)
Table Global Cancer Drug Therapy Sales Share by End User (2014-2019)
Figure Global Sales Cancer Drug Therapy Market Share by End User (2014-2019)
Figure Global Sales Cancer Drug Therapy Market Share by End User in 2018
Figure North America Cancer Drug Therapy Sales Growth Rate 2014-2019 (K Units)
Figure North America Cancer Drug Therapy Revenue Growth Rate 2014-2019 (Million US$)
Table North America Cancer Drug Therapy Sales by Countries (2014-2019) (K Units)
Table North America Cancer Drug Therapy Sales Market Share by Countries (2014-2019)
Figure 2018 North America Cancer Drug Therapy Sales Market Share by Countries
Table North America Cancer Drug Therapy Revenue by Countries (2014-2019) (Million US$)
Table North America Cancer Drug Therapy Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Cancer Drug Therapy Revenue Market Share by Countries
Figure United States Cancer Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure United States Cancer Drug Therapy Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Cancer Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Canada Cancer Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Cancer Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Cancer Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Table North America Cancer Drug Therapy Sales by Product (2014-2019) (K Units)
Table North America Cancer Drug Therapy Sales Market Share by Product (2014-2019)
Figure 2018 North America Cancer Drug Therapy Market Share by Product
Table North America Cancer Drug Therapy Sales by End User (2014-2019) (K Units)
Table North America Cancer Drug Therapy Sales Market Share by End User (2014-2019)
Figure 2018 North America Cancer Drug Therapy Market Share by End User
Figure Europe Cancer Drug Therapy Sales Growth Rate 2014-2019 (K Units)
Figure Europe Cancer Drug Therapy Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Cancer Drug Therapy Sales by Countries (2014-2019) (K Units)
Table Europe Cancer Drug Therapy Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Cancer Drug Therapy Sales Market Share by Countries
Table Europe Cancer Drug Therapy Revenue by Countries (2014-2019) (Million US$)
Table Europe Cancer Drug Therapy Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Cancer Drug Therapy Revenue Market Share by Countries
Figure Germany Cancer Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Germany Cancer Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure France Cancer Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure France Cancer Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Cancer Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure UK Cancer Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Cancer Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Italy Cancer Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Cancer Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Russia Cancer Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Cancer Drug Therapy Sales by Product (2014-2019) (K Units)
Table Europe Cancer Drug Therapy Sales Market Share by Product (2014-2019)
Figure 2018 Europe Cancer Drug Therapy Market Share by Product
Table Europe Cancer Drug Therapy Sales by End User (2014-2019) (K Units)
Table Europe Cancer Drug Therapy Sales Market Share by End User (2014-2019)
Figure 2018 Europe Cancer Drug Therapy Market Share by End User
Figure Asia Pacific Cancer Drug Therapy Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Cancer Drug Therapy Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Cancer Drug Therapy Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Cancer Drug Therapy Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Cancer Drug Therapy Sales Market Share by Countries
Table Asia Pacific Cancer Drug Therapy Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Cancer Drug Therapy Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Cancer Drug Therapy Revenue Market Share by Countries
Figure China Cancer Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure China Cancer Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Cancer Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Japan Cancer Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Cancer Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Korea Cancer Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure India Cancer Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure India Cancer Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Cancer Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Australia Cancer Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Cancer Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Cancer Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Cancer Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Cancer Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Cancer Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Cancer Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Cancer Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Cancer Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Cancer Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Cancer Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Cancer Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Cancer Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Cancer Drug Therapy Sales by Product (2014-2019) (K Units)
Table Asia Pacific Cancer Drug Therapy Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Cancer Drug Therapy Market Share by Product
Table Asia Pacific Cancer Drug Therapy Sales by End User (2014-2019) (K Units)
Table Asia Pacific Cancer Drug Therapy Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Cancer Drug Therapy Market Share by End User
Figure Central & South America Cancer Drug Therapy Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Cancer Drug Therapy Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Cancer Drug Therapy Sales by Countries (2014-2019) (K Units)
Table Central & South America Cancer Drug Therapy Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Cancer Drug Therapy Sales Market Share by Countries
Table Central & South America Cancer Drug Therapy Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Cancer Drug Therapy Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Cancer Drug Therapy Revenue Market Share by Countries
Figure Brazil Cancer Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Cancer Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Cancer Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Cancer Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Cancer Drug Therapy Sales by Product (2014-2019) (K Units)
Table Central & South America Cancer Drug Therapy Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Cancer Drug Therapy Market Share by Product
Table Central & South America Cancer Drug Therapy Sales by End User (2014-2019) (K Units)
Table Central & South America Cancer Drug Therapy Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Cancer Drug Therapy Market Share by End User
Figure Middle East and Africa Cancer Drug Therapy Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Cancer Drug Therapy Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Cancer Drug Therapy Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Cancer Drug Therapy Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Cancer Drug Therapy Sales Market Share by Countries
Table Middle East and Africa Cancer Drug Therapy Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Cancer Drug Therapy Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Cancer Drug Therapy Revenue Market Share by Countries
Figure GCC Countries Cancer Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Cancer Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Cancer Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Cancer Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Cancer Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Cancer Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Cancer Drug Therapy Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Cancer Drug Therapy Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Cancer Drug Therapy Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Cancer Drug Therapy Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Cancer Drug Therapy Market Share by Product
Table Middle East and Africa Cancer Drug Therapy Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Cancer Drug Therapy Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Cancer Drug Therapy Market Share by End User
Table Amgen / Allergan Company Details
Table Amgen / Allergan Cancer Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Amgen / Allergan Recent Development
Table Argos Therapeutics Company Details
Table Argos Therapeutics Cancer Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Argos Therapeutics Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Cancer Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development
Table Aveo Pharmaceuticals Company Details
Table Aveo Pharmaceuticals Cancer Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Aveo Pharmaceuticals Recent Development
Table Bayer Company Details
Table Bayer Cancer Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer Recent Development
Table Exelixis Company Details
Table Exelixis Cancer Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Exelixis Recent Development
Table Incyte Company Details
Table Incyte Cancer Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Incyte Recent Development
Table Merck Company Details
Table Merck Cancer Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Recent Development
Table Roche Company Details
Table Roche Cancer Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Cancer Drug Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Eisai Company Details
Table Exelixis Company Details
Table Genentech (Roche) Company Details
Table Novartis Company Details
Table Pfizer Company Details
Table Prometheus Labs Company Details
Table Global Cancer Drug Therapy Sales Forecast by Regions 2019-2025 (K Units)
Table Global Cancer Drug Therapy Sales Market Share Forecast by Regions 2019-2025
Table Global Cancer Drug Therapy Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Cancer Drug Therapy Revenue Market Share Forecast by Regions 2019-2025
Table Global Cancer Drug Therapy Sales Forecast by Product 2019-2025 (K Units)
Table Global Cancer Drug Therapy Sales Market Share Forecast by Product 2019-2025
Table Global Cancer Drug Therapy Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Cancer Drug Therapy Revenue Market Share Forecast by Product 2019-2025
Table Global Cancer Drug Therapy Sales Forecast by End User 2019-2025 (K Units)
Table Global Cancer Drug Therapy Sales Market Share Forecast by End User 2019-2025
Figure North America Cancer Drug Therapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Cancer Drug Therapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Cancer Drug Therapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Cancer Drug Therapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Cancer Drug Therapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Cancer Drug Therapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Cancer Drug Therapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Cancer Drug Therapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Cancer Drug Therapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Cancer Drug Therapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Cancer Drug Therapy Value Chain
Table Cancer Drug Therapy Customers List
Table Cancer Drug Therapy Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs